Bain Capital Specialty Finance, Inc. (BCSF) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BCSF SEC filings page.
This page shows Bain Capital Specialty Finance, Inc. (BCSF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported assets expanded modestly, but falling earnings, weaker operating cash generation, and greater creditor financing define how this investment vehicle is structured.
From FY2023 to FY2025, net income fell20.0% while operating cash flow fell86.5% ; the simultaneous deterioration indicates weaker cash conversion, not merely lower accounting earnings. The reported profit stream therefore became less representative of cash available for distributions.
FY2025 total assets were
Interest expense reached
Financial Health Signals
Bain Capital Specialty Finance, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Bain Capital Specialty Finance, Inc. passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Key Financial Metrics
Earnings & Revenue
Bain Capital Specialty Finance, Inc. reported $14.1M in net income in Q2 2026. This represents a decrease of 40.8% from the same quarter a year earlier. Against the prior quarter it is up 314.6%.
Bain Capital Specialty Finance, Inc. earned $0.22 per diluted share (EPS) in Q2 2026. This represents a decrease of 40.5% from the same quarter a year earlier. Against the prior quarter it is up 340.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Bain Capital Specialty Finance, Inc. held $97.2M in cash against $1.5B in long-term debt as of Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
Bain Capital Specialty Finance, Inc.'s quarterly ROE was 1.3% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
BCSF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-K |
|---|---|---|---|---|---|---|---|---|
| Interest Expense | $20.7M-5.1% | $20.3M+7.1% | N/A | $20.3M+12.1% | $21.8M+23.5% | $18.9M+4.7% | N/A | $18.1M-12.8% |
| Income Tax | N/A | N/A | N/A | N/A | N/A | $0n/m | N/A | N/A |
| Net Income | $14.1M-40.8% | $3.4M-88.1% | $27.8M+25.5% | $18.7M-43.5% | $23.7M-18.5% | $28.5M-18.7% | $22.1M-28.7% | $33.1M-2.2% |
| EPS (Basic) | $0.22-40.5% | $0.05-88.6% | $0.43+26.5% | $0.29-43.1% | $0.37-17.8% | $0.44-20.0% | $0.34-29.2% | $0.51-1.9% |
| EPS (Diluted) | $0.22-40.5% | $0.05-88.6% | $0.43+26.5% | $0.29-43.1% | $0.37-17.8% | $0.44-20.0% | $0.34-29.2% | $0.51-1.9% |
| Diluted Shares (Avg) | 65M0.0% | 65M+0.3% | N/A | 65M+0.5% | 65M+0.5% | 65M+0.2% | N/A | 65M0.0% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
BCSF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.6B-5.6% | $2.6B-1.5% | $2.7B+1.2% | $2.7B+6.8% | $2.8B+14.9% | $2.6B+2.4% | $2.6B+6.5% | $2.5B-0.9% |
| Cash & Equivalents | $97.2M+249.1% | $13.0M+27.6% | $23.1M-55.2% | $40.9M+61.3% | $27.8M+51.2% | $10.2M-78.2% | $51.6M+19.9% | $25.3M-61.1% |
| Total Liabilities | $1.5B-5.8% | $1.5B+0.7% | $1.5B+3.5% | $1.6B+13.6% | $1.6B+28.5% | $1.5B+4.2% | $1.5B+11.7% | $1.4B-2.6% |
| Long-Term Debt | $1.5B-3.9% | $1.5B+0.2% | $1.5B+5.8% | $1.5B+15.1% | $1.6B+33.1% | $1.5B+6.9% | $1.4B+10.7% | $1.3B-5.1% |
| Total Equity | $1.1B-5.2% | $1.1B-4.5% | $1.1B-2.0% | $1.1B-1.6% | $1.1B-0.3% | $1.1B+0.2% | $1.1B+0.3% | $1.1B+1.2% |
| Retained Earnings | -$80.8Mn/m | -$67.6Mn/m | -$43.8Mn/m | -$35.6Mn/m | -$25.1Mn/m | -$19.6Mn/m | -$19.9Mn/m | -$18.7Mn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
BCSF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $70.8M+10857.6% | $26.6Mn/m | $27.2Mn/m | $9.0Mn/m | $646K-99.7% | -$7.3Mn/m | -$20.0M-113.4% | -$135.9M-211.1% |
| Financing Cash Flow | $26.8M-65.6% | -$51.3M-2687.7% | -$54.8M-191.4% | -$96.9M-199.9% | $77.8Mn/m | $2.0M-97.3% | $59.9Mn/m | $96.9Mn/m |
| Dividends Paid | $27.2M-6.7% | $37.0M-36.5% | $29.2M+0.5% | $29.2M+0.5% | $29.2M+0.5% | $58.2M+114.8% | $29.1M+7.1% | $29.1M+18.4% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Share Buybacks.
BCSF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-K |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | 1.3%-0.8pp | 0.3%-2.2pp | 2.5%+0.5pp | 1.7%-1.2pp | 2.1%-0.5pp | 2.5%-0.6pp | 1.9%-0.8pp | 2.9%-0.1pp |
| Return on Assets | 0.5%-0.3pp | 0.1%-1.0pp | 1.0%+0.2pp | 0.7%-0.6pp | 0.9%-0.3pp | 1.1%-0.3pp | 0.8%-0.4pp | 1.3%0.0pp |
| Debt-to-Equity | 1.390.0x | 1.33+0.1x | 1.32+0.1x | 1.33+0.2x | 1.37+0.3x | 1.27+0.1x | 1.22+0.1x | 1.13-0.1x |
| Liabilities-to-Equity | 1.430.0x | 1.38+0.1x | 1.38+0.1x | 1.41+0.2x | 1.44+0.3x | 1.31+0.1x | 1.31+0.1x | 1.220.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Current Ratio, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Bain Capital Specialty Finance, Inc. BCSF | FY2025 | N/A | $98.8M | N/A | $653.2M | — |
| Kayne Anderson BDC, Inc. KBDC | FY2025 | N/A | $93.7M | N/A | $842.6M | — |
| PennantPark Floating Rate Capital Ltd. PFLT | FY2025 | N/A | $66.4M | N/A | $633.0M | — |
| Carlyle Secured Lending, Inc. CGBD | FY2025 | N/A | $70.0M | N/A | $703.2M | — |
| Barings BDC, Inc. BBDC | FY2025 | N/A | $101.9M | N/A | $870.1M | — |
Where Bain Capital Specialty Finance, Inc. Ranks
Frequently Asked Questions
Is Bain Capital Specialty Finance, Inc. profitable?
Yes, Bain Capital Specialty Finance, Inc. (BCSF) reported a net income of $63.9M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $98.8M.
How much debt does Bain Capital Specialty Finance, Inc. have?
As of fiscal year 2025, Bain Capital Specialty Finance, Inc. (BCSF) had $23.1M in cash and equivalents against $1.5B in long-term debt.
What is Bain Capital Specialty Finance, Inc.'s return on equity (ROE)?
Bain Capital Specialty Finance, Inc. (BCSF) has a return on equity of 8.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Bain Capital Specialty Finance, Inc.'s operating cash flow?
Bain Capital Specialty Finance, Inc. (BCSF) generated $29.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Bain Capital Specialty Finance, Inc.'s total assets?
Bain Capital Specialty Finance, Inc. (BCSF) had $2.7B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Bain Capital Specialty Finance, Inc.'s debt-to-equity ratio?
Bain Capital Specialty Finance, Inc. (BCSF) had a debt-to-equity ratio of 1.32 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Bain Capital Specialty Finance, Inc.'s liabilities-to-equity ratio?
Bain Capital Specialty Finance, Inc. (BCSF) had a liabilities-to-equity ratio of 1.38 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Bain Capital Specialty Finance, Inc.'s return on assets (ROA)?
Bain Capital Specialty Finance, Inc. (BCSF) had a return on assets of 3.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Bain Capital Specialty Finance, Inc.'s P/E ratio?
Bain Capital Specialty Finance, Inc. (BCSF) trades at 10.2x earnings, its market capitalization divided by $63.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $653.2M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Bain Capital Specialty Finance, Inc.'s price-to-sales ratio?
Bain Capital Specialty Finance, Inc. (BCSF) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $653.2M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Bain Capital Specialty Finance, Inc.'s Piotroski F-Score?
Bain Capital Specialty Finance, Inc. (BCSF) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.